Skip to main content
SpringerLink
Log in

Theophylline and New Generation Phosphodiesterase Inhibitors in the Treatment of Asthma

  • Chapter
Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends

Part of the book series: Respiratory Pharmacology and Pharmacotherapy ((RPP))

  • 101 Accesses

Abstract

Theophylline has been in clinical use for more than a century, although it is only during the last 50 years that this drug has been in regular use for the treatment of asthma. Theophylline was first used in the treatment of asthma in 1937, when it was administered i.v. for the treatment of acute asthma. In 1940, theophylline was first used orally in combination with ephedrine, and there are now many studies in the literature describing the effects of theophylline in the treatment of asthma [1]. Theophylline is now most commonly used in various slow-release formulations to overcome its rapid metabolism. However, over the last decade, the number of prescriptions being written for theophylline has declined, as newer medications have been introduced for the treatment of asthma, and this decline has come about mainly due to concerns about the narrow therapeutic window of theophylline, which has typically been classified as being 10-20.μg/ml in plasma [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weinberger M, Hendeles L (1996) Theophylline in asthma. N Engl J Med 334: 636–42

    Article  Google Scholar 

  2. Spina D, Landells LJ, Page CP (1998) The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as anti-inflammatory drugs. Clin Exp Allergy 28: 24–34

    PubMed  CAS  Google Scholar 

  3. Ward AJM, Mc Kenniff M, Evans JM, Page CP, Costello JF (1993) Theophylline—an immunomodulatory role in asthma? Am Rev Respir Dis 147: 518–523

    PubMed  CAS  Google Scholar 

  4. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ (1995) Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 151: 1907–1914

    PubMed  CAS  Google Scholar 

  5. Ashutosh K, Sedat M, Fragale-Jackson J (1997) Effect of theophylline on respiratory drive in patients with chronic obstructive pulmonary disease. J Clin Pharmacol 37: 1100–1107

    PubMed  CAS  Google Scholar 

  6. Pauwels R, Van Renterghem D, Van der Straeten M, Johannesson N, Persson CGA (1985) The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allerg Clin Immunol 76: 583–590

    Article  CAS  Google Scholar 

  7. Crescioli S, Spinazzi A, Plebani M, Pozzani M, Napp CE, Boschetto P, Fabbri LM (1992) Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann Allergy 66: 245–251

    Google Scholar 

  8. Hendeles L, Harman E, Huang D, O’Brien R, Blake K, Delafuente J (1995) Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered dose inhaled. JAllerg Clin Immunol 95: 505–514

    Article  CAS  Google Scholar 

  9. Cockcroft DW, Murdock KY, Gore BP, O’Byrne PM, Manning P (1989) Theophylline does not inhibit allergen induced increase in airway responsiveness to methacholine. J Allerg Clin Immunol 83(5): 913–920

    Article  CAS  Google Scholar 

  10. De Monchy JGR, Kauffman HP, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K (1985) Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 131: 373–376

    PubMed  Google Scholar 

  11. Sullivan PJ, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J (1994) Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343: 1006–1008

    Article  PubMed  CAS  Google Scholar 

  12. Aubier M, Neukirch C, Maachi M, Boucara D, Engelstatter R, Steinijans V, Samoyeau R, Dehoux M (1998) Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis. Eur Resp J 11: 1105–1110

    Article  CAS  Google Scholar 

  13. Limatibul S, Shore A, Dorsch HM, Gelfard E (1987) Theophylline modulation of E-rosette formation: an indication of T-cell maturation. Clin Exp Immunol 33: 503–513

    Google Scholar 

  14. Pardi R, Zocchi M, Ferrero E, Cibaldo GF, Inverandi L, Rugarli C (1984) In vivo effects of a single infusion of theophylline on human peripheral blood lymphocytes. Clin Exp Immunol 57: 722–728

    PubMed  CAS  Google Scholar 

  15. Mary D, Aussel C, Ferrua B, Fehlmann M (1987) Regulation of interleukin-2 synthesis by cAMP in human T cells. J Immunol 139: 1179–1184

    PubMed  CAS  Google Scholar 

  16. Scordamaglia A, Ciprandi G, Ruffoni S, Caria M, Paolieri F, Venuti D, Cannonica GW (1988) Theophylline and the immune response: in vitro and in vivo effects. Clin Immunol Immunopathol 48: 238–246

    Article  PubMed  CAS  Google Scholar 

  17. Shohat B, Volovitz B, Varsano I (1983) Induction of suppressor T Cells in asthmatic children by theophylline treatment. Clin Allergy 13: 487–493

    Article  PubMed  CAS  Google Scholar 

  18. Hamid Q, Azzawi M, Ying S et al (1991) Expression of MRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 87: 1541–1546

    Article  PubMed  CAS  Google Scholar 

  19. Jaffar Z, Sullivan PJ, Page CP, Costello JF (1996) Low dose theophylline therapy modulates T-lymphocyte activity in subjects with atopic asthma. Eur Resp J 9: 456–463

    Article  CAS  Google Scholar 

  20. Fink G, Mittelman M, Shohat B, Spitzer SA (1987) Theophylline-induced alterations in cellular immunity in asthmatic patients. Clin Allergy 17: 313–316

    Article  PubMed  CAS  Google Scholar 

  21. Brenner MR, Berkowitz R, Marshall N, Strunk RC (1988) Need for theophylline in severe steroid-requiring asthmatics Clin Allergy 18: 143–150

    Article  PubMed  CAS  Google Scholar 

  22. Finnerty JP, Wilson LS, Madden J, Djukanovic R, Holgate ST (1996) Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study. Eur Respir J 9: 1672–1677

    Article  PubMed  CAS  Google Scholar 

  23. Mascali JJ, Cvietusa P, Negri J, Borish L (1996) Anti-inflammaatory effects of theophylline: modulation of cytokine production. Ann Allergy Asthma Immunol 77: 34–38

    Article  PubMed  CAS  Google Scholar 

  24. Punnonen J, de Wall Malefyt R, van Vlasselaer P (1993) IL-10 and viral IL-10 prevent IL-4 induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 151: 1280–1289

    PubMed  CAS  Google Scholar 

  25. Enk AH, Angeloni VL, Udey MC, Katz SI (1993) Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 151: 2390–2398

    PubMed  CAS  Google Scholar 

  26. Yamouguchi Y, Hayashi Y, Sugama Y (1988) Highly purified mutine interleukin-5 (IL-5) stimulates eosinophil function and prolonges in vitro survival: IL-5 as an eosinophil chemotactic factor. J Exp Med 167: 1737–1742

    Article  Google Scholar 

  27. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A (1997) Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 7: 1677–1684

    Article  Google Scholar 

  28. Barnes PJ, Pauwels RA (1994) Theophylline in the management of asthma: time for reappraisal? Eur Respir J 7: 579–591

    Article  PubMed  CAS  Google Scholar 

  29. Banner KH, Page CP (1997) Prostaglandins contribute to the anti-proliferative effect of isoenzyme selective phosphodiesterase 4 inhibitors but not theophylline in human mononuclear cells. Br J Pharmacol 120: 11P

    Google Scholar 

  30. Peterson TC, Slysz G, Isbrucker R (1998) The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinctive from an effect by cyclic AMP. Immunopharmacology 39: 181–191

    Article  PubMed  CAS  Google Scholar 

  31. Persson CGA, Pauwels R (1989) Pharmacology of Anti-Asthma Xanthines. In: CP Page, PJ Barnes (eds): Pharmacology of Asthma. Academic Press London 7: 207–225

    Google Scholar 

  32. Feoktistov I, Biaggioni I (1995) A2b Receptors evoke interleukin-8 secretion in human mast cells. An eroprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96: 1979–1986

    Article  PubMed  CAS  Google Scholar 

  33. Feoktistov I, Polosa R, Holgate ST, Baggioni I (1998) Adenosine A2b receptors: novel therapeutic target in asthma? Trends Pharmacol Sci 19: 148–153

    Article  PubMed  CAS  Google Scholar 

  34. Cushley MJ, Tattersfield AE, Holgate ST (1983) Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15: 161–165

    Article  PubMed  CAS  Google Scholar 

  35. Mann JS, Holgate ST (1985) Specific antagonism of adenosine-induced broncocosntriction in asthma by oral theophylline. Br J Clin Pharmacol 19: 685–692

    Article  PubMed  CAS  Google Scholar 

  36. Cushley MJ, Tattersfield AE, Holgate ST (1984) Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis 129: 380–384

    PubMed  CAS  Google Scholar 

  37. El-Hashim A, D’Agostino B, Matera MG, Page CP (1996) Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br J Pharmacol 119: 1262–1268

    Article  PubMed  Google Scholar 

  38. Ali S, Mustafa SJ, Metzger WJ (1994) Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in an allergic rabbit model. Am J Physiol 266: L271–L277

    PubMed  CAS  Google Scholar 

  39. Nyce JW, Metzger WJ (1997) An anti-sense oligonucleotide against Al receptors inhibits allergen-induced airway responsiveness in allergic rabbits. Nature 97: 721–725

    Article  Google Scholar 

  40. Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ (1996) Theophylline: potential antiinflammatory effects in nocturnal asthma. JAllerg Clin Immunol 97: 1242–1246

    Article  CAS  Google Scholar 

  41. D’Alonzo G, Smolensky M, Feldman S (1990) Twenty-four hour lung function in adult patients with asthma. Am Rev Respir Dis 142: 84–90

    PubMed  Google Scholar 

  42. Nielson CP, Crowley JJ, Cusak BJ, Vestal RE (1986) Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation. J Allerg Clin Immunol 76: 660–667

    Article  Google Scholar 

  43. Nielson CP, Crawley JJ, Morgan ME, Vestal RE (1988) Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic 3’, 5’ adenosine monophosphate. Am Rev Respir Dis 137: 25–30

    Article  PubMed  CAS  Google Scholar 

  44. Page CP, Cotter T, Kilfeather S, Sullivan P, Spina D, Costello JF (1998) The effect of chronic theophylline treatment on position and shape of the methacholine dose-response curve in allergic asthmatic subjects. Eur Resp J 12: 24–29

    Article  CAS  Google Scholar 

  45. Magnussen H, Reuss G, Jorres R (1987) Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics. Am Rev Respir Dis 136: 1163–1167

    Article  PubMed  CAS  Google Scholar 

  46. Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ (1991) The productive effect of inhaled corticosteroid on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 43: 109–113

    Google Scholar 

  47. Bel EH, Zwinderman AH, Timmers MC, Dijkman JH, Sterk PJ (1991) The protective effect of a beta 2 against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax 46: 9–14

    Article  PubMed  CAS  Google Scholar 

  48. Evans DJ, Talor DA, Zetterstrom O, Chung KF, O’Connor BJ, Barnes PJ (1997) A comparison of low-dose inhaled budesonide plus theophylline and high-dose budesonide for moderate asthma. NEng J. Med 337: 1412–1418

    Article  CAS  Google Scholar 

  49. Rivington RN, Boulet L-P, Cote J et al (1995) Efficacy of uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med 151: 325–332

    PubMed  CAS  Google Scholar 

  50. Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, Leichtl S, Rathgeb F, Keller A, Steinijans VW (1997) Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma Eur Respir J 10: 2754–2760

    Article  PubMed  CAS  Google Scholar 

  51. Tinkelman DG, Reed CE, Nelson HS, Offord KP et al (1993) Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Paediatrics 92(1): 64–77

    CAS  Google Scholar 

  52. Kellaway JS, Wyatt RA, Addis SA (1994) Comparison of patients compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 154: 1349–1354

    Article  Google Scholar 

  53. Barnes PJ, Jonsson B, Klim JP (1996) The cost of asthma Eur Resp J 9: 636–642

    Article  CAS  Google Scholar 

  54. Peachell PT, Undem BJ, Schleimer RP, Mac Glashan DW Jr, Lichtenstein LM, Cielinski LB, Torphy TJ (1992) Preliminary identification and role of phosphodiesterase isoenzymes in human basophils J Immunol 148: 2503–2510

    PubMed  CAS  Google Scholar 

  55. Muller T, Engels P, Fozard JR (1996) Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends Pharmacol Sci 17: 294–298

    Article  PubMed  CAS  Google Scholar 

  56. Sounes JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MN, Karlsson JA (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFa generation from human monocytes by interacting with a low-affinity’ phosphodiesterase 4 conformer Br J Pharmacol 118: 649–658

    Article  Google Scholar 

  57. Tenor H, Staniciu L, Schudt C, Hatzelmann A, Wendel A, Djukanovic R, Church MK, Shute JK (1995). Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes. Clin Exp Allergy 25: 616–624

    Article  PubMed  CAS  Google Scholar 

  58. Giembycz MA, Corrigan CJ, Seybold J, Newton R, Barnes PJ (1996) Identification of cyclic AMP phosphodiesterase 3,4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol 118: 1945–1958

    Article  PubMed  CAS  Google Scholar 

  59. Schudt C, Tenor H, Hatzelmann A (1995) PDE isoenzymes as targets for anti-asthma drugs Eur Respir J 8: 1179–1183

    Article  PubMed  CAS  Google Scholar 

  60. Souness JE, Diocee BK, Martin W, Moodie SA (1990) Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Biochem J 266: 127–132

    PubMed  CAS  Google Scholar 

  61. Howell RE, Sickels BD, Woeppel SL (1993) Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther 264: 609–615

    PubMed  CAS  Google Scholar 

  62. Underwood DC, Osborn RR, Novak LB, Matthews JK, Newsholme SJ, Undem BJ, Hand JM, Torphy TJ (1993) Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 266: 306–313

    PubMed  CAS  Google Scholar 

  63. Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttmann MA, Hay DW, Torphy TJ (1994) Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J Pharmacol Exp Ther 270: 250–259

    PubMed  CAS  Google Scholar 

  64. Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE, et al (1994) Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 113: 1423–1431

    Article  PubMed  CAS  Google Scholar 

  65. Nagai H, Takeda H, Iwama T, Yamaguchi S, Mori H (1995) Studies on anti-allergic action of AH 21–132, a novel isozyme-selective phosphodiesterase inhibitor in airways. Jpn J Pharmacol 67: 149–156

    Article  PubMed  CAS  Google Scholar 

  66. Hughes B, Howat D, Lisle H, Holbrook M, Tames T, Gozzard N, Blease K, Hughes P, Kingaby R, Warrellow G et al (1996) The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4. Br J Pharmacol 118: 1183–1191

    Article  PubMed  CAS  Google Scholar 

  67. Ortiz JL, Valles JM, MartiCabrera M, Cortijo J, Morcillo EJ (1996) Effects of selective phosphodiesterase inhibitors on platelet-activating factor-and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs. Naunyn-Schmied Arch Pharmacol 353: 200–206

    Article  CAS  Google Scholar 

  68. Gozzard N, El-Hashim A, Herd CM, Blake SM, Holbrook M, Hughes B, Higgs GA, Page CP (1996a). Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally inununised rabbits. Br J Pharmacol 118: 1201–1208

    Article  CAS  Google Scholar 

  69. Gozzard N, Herd CM, Blake SM, Holbrook M, Hughes B, Higgs GA, Page CP (1996b). Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits. Br J Pharmacol 117: 1405–1412

    Article  CAS  Google Scholar 

  70. Kings MA, Chapman I, Kristersson A, Sanjar S, Morley J (1990) Human recombinant lymphokines and cytokines induce pulmonary eosinophilia in the guinea pig which is inhibited by ketotifen and AH 21–132. Int Arch Allergy Appl Immunol 91: 354–361

    Article  PubMed  CAS  Google Scholar 

  71. Lagente V, Pruniaux MP, Junien JL, Moodley I (1995) Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 151: 1720–1724

    PubMed  CAS  Google Scholar 

  72. Lagente V, Moodley I, Perrin S, Mottin G, Junien JL (1994) Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung. Eur J Pharmacol 255: 253–256

    Article  PubMed  CAS  Google Scholar 

  73. Banner KH, Marchini F, Buschi A, Moriggi E, Semeraro C, Page CP (1995) The effect of selective phosphodiesteraseinhibitors in comparison with other anti-asthma drugs on allergen-induced eosinophilia in guinea-pig airways. Pulm Pharmacol 8: 37–42

    Article  PubMed  CAS  Google Scholar 

  74. Raeburn D, Souness JE, Tomkinson A, Karlsson JA (1993) Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma. Prog Drug Res 40: 9–32

    PubMed  CAS  Google Scholar 

  75. Turner CR, Andresen CJ, Smith WB, Watson JW (1994) Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care Med 149: 1153–1159

    PubMed  CAS  Google Scholar 

  76. Elwood W, Sun J, Barnes PJ, Giembycz MA, Chung KF (1995) Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in brown-Norway rats. Inflamm Res 44: 83–86

    Article  PubMed  CAS  Google Scholar 

  77. Howell RE, Jenkins LP, Fielding LE, Grimes D (1995) Inhibition of antigen-induced pulmonary eosinophilia and neutrophilia by selective inhibitors of phosphodiesterase types 3 or 4 in Brown Norway rats. Pulm Pharmacol 8: 83–89

    Article  PubMed  CAS  Google Scholar 

  78. Turner CR, Cohan VL, Cheng JB, Showell HJ, Pazoles CJ, Watson JW (1996) The in vivo pharmacology of CP-80,633, a selective inhibitor of phosphodiesterase 4. J Pharmacol Exp Ther 278: 1349–1355

    PubMed  CAS  Google Scholar 

  79. Schudt C, Winder S, Eltze M, Kilian U, Beume R (1991b). Zardaverine: a cyclic AMP specific PDE 1I1/W inhibitor. Agents Actions Suppl 34: 379–402

    CAS  Google Scholar 

  80. Kips JC, Joos GF, Peleman RA, Pauwels RA (1993) The effect of zardaverine, an inhibitor of phosphodiesterase isoenzymes III and IV, on endotoxin-induced airway changes in rats. Clin Exp Allergy 23: 518–523

    Article  PubMed  CAS  Google Scholar 

  81. Sanjar S, Aoki S, Boubekeur K, Chapman ID, Smith D, Kings MA, Morley J (1990a). Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs. Br J Pharmacol 99: 267–272

    Article  CAS  Google Scholar 

  82. Sanjar S, Aoki S, Kristersson A, Smith D, Morley J (1990b). Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs. Br J Pharmacol 99: 679–686

    Article  CAS  Google Scholar 

  83. Banner KH, Page CP (1995) Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br J Pharmacol 114: 93–98

    Article  PubMed  CAS  Google Scholar 

  84. Manzini S, Perretti F, Abelli L, Evangelista S, Seeds EA, Page CP (1993) Isbufylline, a new xanthine derivative, inhibits airway hyperresponsiveness and airway inflammation in guinea pigs. Eur J Pharmacol 249: 251–257

    Article  PubMed  CAS  Google Scholar 

  85. Holbrook M, Gozzard N, James T, Higgs G, Hughes B (1996) Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Br J Pharmacol 118: 1192–1200

    Article  PubMed  CAS  Google Scholar 

  86. Kawasaki A, Hoshino K, Osaki R, Mizushima Y, Yano S (1992) Effect of ibudilast: a novel anti-asthmatic agent, on airway hypersensitivity in bronchial asthma JAsthma 29: 245–252

    Article  CAS  Google Scholar 

  87. Harbinson PL, Mac Leod D, Hawksworth R, O’Toole S, Sullivan PJ, Heath P, Kilfeather S, Page CP, Costello J, Holgate ST, Lee TH (1997) The effect of a novel orally active selective PDE4 isoenzyme inhibitor CDP840 on allergen-induced responses in asthmatic subjects. Eur Respir J 10: 1008–1914

    Article  PubMed  CAS  Google Scholar 

  88. Landells LJ, Jensen MW, Spina D, Donigi Gale D, Miller AJ, Nichols T, Smith K, Rotshetyn Y, Burch RM, Page CP, O’Connor BJ (1998) Oral adminsitration of the phosphodiesterase (PDE) 4 inhibitor, V 11294A inhibits ex vivo agonist-induced cell activation. Eur Respir J 12: 362

    Google Scholar 

  89. Torphy TJ, Murduch RD, Nieman R, Compton CH (1998) Ariflo (SB 207499), a second generation PDE4 inhibitor for the treatment of asthma and COPD. In:Proceedings of New Drug for Asthma IV, Official Satellite of the XIII IUPHAR Symposium, Konstanz, July 23–25, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pharmacology & Therapeutics, Guy’s King’s & St. Thomas’, School of Biomedical Sciences, Sackler Institute of Pulmonary Pharmacology, 5th Floor, Hodgkin Building, Guy’s Campus, London, SE1 9RT, UK

    Clive P. Page

  2. Department of Respiratory Medicine & Allergy, Guy’s King’s & St Thomas’s School of Medicine, King’s College London, Bessemer Road, London, SE5, UK

    John Costello

Authors
  1. Clive P. Page
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Costello
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Thoracic Medicine, Imperial College of Science, Technology and Medicine, National Heart and Lung Institute, London, SW3 6LY, England

    Mark A. Giembycz

  2. Clinical Studies Unit, The Royal Brompton National Heart and Lung Hospital, Sydney Street, London, SW3 6NP, England

    Brian J. O’Connor

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Basel AG

About this chapter

Cite this chapter

Page, C.P., Costello, J. (2000). Theophylline and New Generation Phosphodiesterase Inhibitors in the Treatment of Asthma. In: Giembycz, M.A., O’Connor, B.J. (eds) Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8480-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8480-8_10

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9585-9

  • Online ISBN: 978-3-0348-8480-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation